Akinori Urae

1.5k total citations
30 papers, 1.2k citations indexed

About

Akinori Urae is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Akinori Urae has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 10 papers in Oncology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Akinori Urae's work include Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (9 papers) and Pharmaceutical studies and practices (5 papers). Akinori Urae is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (9 papers) and Pharmaceutical studies and practices (5 papers). Akinori Urae collaborates with scholars based in Japan, United States and Switzerland. Akinori Urae's co-authors include Miyuki Kimura, Shun Higuchi, Ichiro Ieiri, Shin Irie, Kohsuke Mamiya, Kenji Otsubo, Yasufumi Sawada, S. Irie, Toshihiro Morita and Yasuo Kurata and has published in prestigious journals such as Clinical Chemistry, American Journal of Physiology-Heart and Circulatory Physiology and Pharmaceutical Research.

In The Last Decade

Akinori Urae

29 papers receiving 1.2k citations

Peers

Countries citing papers authored by Akinori Urae

Since Specialization

Citations

This map shows the geographic impact of Akinori Urae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akinori Urae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akinori Urae more than expected).

Fields of papers citing papers by Akinori Urae

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akinori Urae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akinori Urae. The network helps show where Akinori Urae may publish in the future.

Co-authorship network of co-authors of Akinori Urae

This figure shows the co-authorship network connecting the top 25 collaborators of Akinori Urae. A scholar is included among the top collaborators of Akinori Urae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akinori Urae. Akinori Urae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of food on the pharmacokinetics of darexaban, an oral direct factor Xa inhibitor, in healthy Japanese subjects 2012 ·International Journal of Clinical Pharmacology and Therapeutics ·Takeshi Kadokura, Yuta Taniuchi, Hiroshi Inoue, Masako Saitō, (unknown), Shunsuke Yamada, Akinori Urae, Mashio Nakamura	3
2	Interaction magnitude, pharmacokinetics and pharmacodynamics of ticlopidine in relation to CYP2C19 genotypic status 2005 ·Pharmacogenetics and Genomics ·Ichiro Ieiri, Miyuki Kimura, Shin Irie, Akinori Urae, Kenji Otsubo, Takashi Ishizaki	25
3	Pharmacogenetic roles of CYP2C19 and CYP2B6 in the metabolism of R- and S-mephobarbital in humans 2004 ·Pharmacogenetics ·Kaoru Kobayashi, Jun Morita, Kan Chiba, (unknown), Miyuki Kimura, Shin Irie, Akinori Urae, Takashi Ishizaki	15
4	Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes 2001 ·Alimentary Pharmacology & Therapeutics ·Yukio Horai, Masahiko Kimura, Hidetoshi Furuie, Kyoko Matsuguma, S. Irie, (unknown), Takashi Nagahama, Manabu Murakami, Toshiyuki Matsui, (unknown), Akinori Urae, Takashi Ishizaki	99
5	Effects of Fexofenadine Hydrochloride on Psychomotor Performance: Comparison of Impaired Performance of a Word Processor by Fexofenadine Hydrochloride with that by d-Chlorpheniramine Maleate in Healthy Volunteers. 2000 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Akinori Urae, Mitsuko Okada, Shin Irie, Takanori Tanaka, (unknown), (unknown), (unknown), Hidetoshi Furuie, (unknown), (unknown), Masako Nishikawa, Shigeyuki Nakano	5
6	Clinical Pharmacology Study of Drug Interaction between Fexofenadine Hydrochloride and Erythromycin: Electrocardiographic Findings and Pharmacokinetics of Concombinant Administration of Fexofenadine Hydrochloride and Erythromycin. 2000 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Akinori Urae, Mitsuko Okada, Ryoji Kimura, (unknown), Hidetoshi Furuie, (unknown), (unknown), Masako Nishikawa, Shin Irie	2
7	Effect of cimetidine and probenecid on pilsicainide renal clearance in humans 2000 ·Clinical Pharmacology & Therapeutics ·Tsuyoshi Shiga, Masayuki Hashiguchi, Akinori Urae, Hiroshi Kasanuki, Tadaaki Rikihisa	32
8	Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects 2000 ·Clinical Pharmacology & Therapeutics ·Hitomi Takanaga, Akihiro Ohnishi, Hisashi Murakami, Hirotami Matsuo, Shun Higuchi, Akinori Urae, S. Irie, Hidetoshi Furuie, (unknown), Motohiro Kimura	92
9	Lack of differences in diclofenac (a substrate for CYP2C9) pharmacokinetics in healthy volunteers with respect to the single CYP2C9 * 3 allele 2000 ·European Journal of Clinical Pharmacology ·(unknown), Ichiro Ieiri, Akinori Urae, Miyuki Kimura, S. Irie, Takeshi Kubota, Kazuhiro Chiba, Takashi Ishizaki, Kohei Otsubo, Shun Higuchi	45
10	Pharmacokinetic analysis of felodipine–grapefruit juice interaction based on an irreversible enzyme inhibition model 2000 ·British Journal of Clinical Pharmacology ·Hitomi Takanaga, Ayako Ohnishi, Hirotami Matsuo, Hideyasu Murakami, (unknown), Ken Kuroda, Akinori Urae, Shun Higuchi, Yasufumi Sawada	46
11	Role of nitric oxide in isoprenaline and sodium nitroprusside‐induced relaxation in human hand veins 1999 ·British Journal of Clinical Pharmacology ·Stephan Chalon, (unknown), Heitor Moreno, Akinori Urae, Terrence F. Blaschke, Brian B. Hoffman	8
12	Reliability of the omeprazole hydroxylation index for CYP2C19 phenotyping: possible effect of age, liver disease and length of therapy 1999 ·British Journal of Clinical Pharmacology ·Miyuki Kimura, Ichiro Ieiri, (unknown), Kohsuke Mamiya, Akinori Urae, (unknown), (unknown), Kenji Otsubo, (unknown)	32
13	Inhibition of angiotensin-converting enzyme in human hand veins 1999 ·Clinical Pharmacology & Therapeutics ·Sylvie Chalon, Gabriella Bedarida, (unknown), (unknown), Akinori Urae, Brenda J. Hoffman, Terrence F. Blaschke	6
14	Genetic Polymorphism of Cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese Population 1998 ·Therapeutic Drug Monitoring ·Miyuki Kimura, Ichiro Ieiri, Kohsuke Mamiya, Akinori Urae, Shun Higuchi	168
15	Endothelial dysfunction in human hand veins is rapidly reversible after smoking cessation 1998 ·American Journal of Physiology-Heart and Circulatory Physiology ·Heitor Moreno, Stephan Chalon, Akinori Urae, Oranee Tangphao, Ademola K. Abiose, Brian B. Hoffman, Terrence F. Blaschke	52
16	Stereoselective 4′‐hydroxylation of phenytoin: relationship to (S)‐mephenytoin polymorphism in Japanese 1997 ·British Journal of Clinical Pharmacology ·Ichiro Ieiri, Kohsuke Mamiya, Akinori Urae, (unknown), Miyuki Kimura, S. Irie, Toshiaki Amamoto, Takeshi Kubota, Shinichi Yoshioka, Katsunori Nakamura, Shigeyuki Nakano, N. Tashiro, Shun Higuchi	28
17	Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, CYP2C19m1 in exon 5 and CYP2C19m2 in exon 4, in Japanese subjects* 1996 ·Clinical Pharmacology & Therapeutics ·Ichiro Ieiri, Takahiro Kubota, Akinori Urae, Miyuki Kimura, (unknown), (unknown), Shinichi Yoshioka, Shin Irie, Toshiaki Amamoto, Kōichi Nakamura, Shigeyuki Nakano, (unknown)	105
18	No Effect of High‐Protein Food on the Stereoselective Bioavailability and Pharmacokinetics of Verapamil 1996 ·The Journal of Clinical Pharmacology ·Masayuki Hashiguchi, (unknown), Akira Maeda, (unknown), (unknown), (unknown), Toshiaki Amamoto, (unknown), (unknown), Shin Irie, Akinori Urae, (unknown), Ryoji Kimura	9
19	The tolerability, pharmacodynamics and pharmacokinetics of Ba37142 (Nicotine TTS) in a repeatedly applied to investigate 1994 ·Medical Entomology and Zoology ·Akinori Urae	0
20	Phase 1 Study of Glucagon (GL-G) Produced by Genetic Engineering Technology. 1991 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Akinori Urae, Shin Irie, Kumiko Makino, Toshiaki Amamoto, (unknown), (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact